Wikidata

(Q39176215)

English

Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer

scientific article published on 22 March 2013

In more languages

Statements

title
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
author name string
Valentina De Falco
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Preziosa Buonocore
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Magesh Muthu
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Liborio Torregrossa
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Fulvio Basolo
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Marc Billaud
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Joseph M Gozgit
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Francesca Carlomagno
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
Massimo Santoro
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
publication date
22 March 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017
page(s)
E811-9
1 reference
stated in
Europe PubMed Central
PubMed ID
23526464
retrieved
9 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39176215&oldid=1811882998"